Dr. Lerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Duke University Hospital
Durham, NC 27710
Education & Training
Duke University HospitalFellowship, Cardiovascular Disease, 2020- Duke University HospitalResidency, Internal Medicine, 2017 - 2020
Icahn School of Medicine at Mount SinaiClass of 2016
Certifications & Licensure
NC State Medical License 2017 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID-19 infection: The PARACOR-19 randomized clinical trial.Stephen J Greene, RaKavius Chambers, Joseph B Lerman, Josephine Harrington, Christopher R deFilippi
European Journal of Heart Failure. 2024-06-01 - Early Outcomes in Patients With LVAD Undergoing Heart Transplant via Use of the SherpaPak Cardiac Transport System.Joseph B Lerman, Chetan B Patel, Sarah Casalinova, Alina Nicoara, Christopher L Holley
Circulation. Heart Failure. 2024-05-01 - 2 citationsDonor Heart Recovery and Preservation Modalities in 2024.Joseph B Lerman, Richa Agarwal, Chetan B Patel, Jeffrey E Keenan, Sarah Casalinova
JACC. Heart Failure. 2024-03-01
Press Mentions
Latest Clinical Evidence Points to Paragonix SherpaPak as a Tool to Reduce Unpredictable, Severe Complications Following Heart TransplantationApril 6th, 2023- In Transporting Donor Hearts, SherpaPak Shows Promise over Traditional CoolersApril 19th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
